Expert Guidance on GLP-1 Receptor Agonists in Type 2 Diabetes: A Case-Based Approach

Learn the glycemic and extraglycemic properties of GLP-1 RA therapies to lower A1C reduce comorbidity risks and improve patient adherence and self-care in the management of T2D.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Novo Nordisk Inc